Top

Published in:

Open Access 01-12-2022 | Migraine | Research

Results of a Web-based survey of 2105 Greek migraine patients in 2020: demographics, clinical characteristics, burden and the effects of the COVID-19 pandemic on the course of migraine

Authors: Emmanouil V. Dermitzakis, Aikaterini Kouroudi, Andreas A. Argyriou, Konstantinos C. Spingos, Konstantinos Bilias, Michail Vikelis

Published in: BMC Neurology | Issue 1/2022

Abstract

The Greek Society of Migraine and Headache Patients (GSMHP), maintaining a strong commitment to research and information, conducted its second web-based online survey named "Migraine in Greece—2020", following its first one conducted in 2018. The 2020 study included 2,105 migraine patients who were called to answer 151 questions. The purposes of the current research were to record the demographic and clinical characteristics of migraine patients in Greece, including the severity and effects of migraine on respondents' quality of life, as well as to survey the effects of the coronavirus pandemic on the course of migraine. Our population, internet-based study provides data that will hopefully contribute to better comprehend the clinical phenotype and course of migraine during the COVID-19 pandemic.

Saylor D, Steiner TJ. The Global burden of Headache. Semin Neurol. 2018;38(2):182–90.CrossRefPubMed

Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301–15.CrossRefPubMed

Manack A, Buse DC, Serrano D, Turkel CC, Lipton RB. Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology. 2011;76(8):711–8.CrossRefPubMed

Messali A, Sanderson JC, Blumenfeld AM, et al. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: a Web-Based Survey. Headache. 2016;56(2):306–22.CrossRefPubMed

Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16(1):86–9.CrossRefPubMed

Torres-Ferrús M, Ursitti F, Alpuente A, et al. School of Advanced Studies of European Headache Federation (EHF-SAS) From transformation to chronification of migraine: pathophysiological and clinical aspects. J Headache Pain. 2020;21(1):42.CrossRefPubMedPubMedCentral

Adams AM, Serrano D, Buse DC, Reed ML, Marske V, Fanning KM, et al. The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results. Cephalalgia. 2015;35(7):563–78.CrossRefPubMedPubMedCentral

Lipton RB, Munjal S, Alam A, Buse DC, Fanning KM, Reed ML, Schwedt TJ, Dodick DW. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences. Headache. 2018;58(9):1408–26.CrossRefPubMed

Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428–32.CrossRefPubMed

10.

Steiner TJ, Stovner LJ, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, et al. The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain. 2014;15(1):31.CrossRefPubMedPubMedCentral

11.

Mavromichalis I, Anagnostopoulos D, Metaxas N. Papanastassiou E Prevalence of migraine in schoolchildren and some clinical comparisons between migraine with and without aura. Headache. 1999;39(10):728–36.CrossRefPubMed

12.

Constantinidis TS, Arvaniti C, Fakas N, Rudolf J, Kouremenos E, Giannouli E, et al. A population-based survey for disabling headaches in Greece: Prevalence, burden and treatment preferences. Cephalalgia. 2021;41(7):810–20.CrossRefPubMed

13.

Dermitzakis EV, Bilias K, Vlachou E, Barmpa E, Vikelis M. Results of an online survey of 1.091 patients with migraine in Greece in 2018. Epidemiological data, treatment options and effectiveness of treatment; the social, economic and emotional impact of the disease. Νευρολογία. 2018;28(5):12–7.

14.

Headache Classification Committee of the International Headache Society (IHS). The International classification of headache disorders, 3rd edition. Cephalalgia. 38(1):1–211.

15.

Vicente-Herrero MT, Ramírez Iñiguez de la Torre MV, Ruiz de la Torre E, Reinoso Barbero L. Symptomatic treatment for migraine. Drugs used and related variables. Results of the European survey on work and migraine. Rev Soc Esp Dolor. 2020;27(3):178–91.

16.

Suzuki K, Takeshima T, Igarashi H, Imai N, Danno D, Yamamoto T, et al. Impact of the COVID-19 pandemic on migraine in Japan: a multicentre cross-sectional study. J Headache Pain. 2021;22(1):53.CrossRefPubMedPubMedCentral

17.

Uygun Ö, Ertaş M, Ekizoğlu E, Bolay H, Özge A, Kocasoy Orhan E, et al. Headache characteristics in COVID-19 pandemic-a survey study. J Headache Pain. 2020;21(1):121.CrossRefPubMedPubMedCentral

18.

Raffaelli B, Mecklenburg J, Scholler S, Overeem LH, Oliveira Gonçalves AS, Reuter U, Neeb L. Primary headaches during the COVID-19 lockdown in Germany: analysis of data from 2325 patients using an electronic headache diary. J Headache Pain. 2021;22(1):59.CrossRefPubMedPubMedCentral

19.

Al-Hashel JY II, Ismail. Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study. J Headache Pain. 2020;21(1):115.CrossRefPubMedPubMedCentral

20.

Dresler T, Caratozzolo S, Guldolf K, Huhn JI, Loiacono C, Niiberg-Pikksööt T, et al. Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications. J Headache Pain. 2019;20(1):51.CrossRefPubMedPubMedCentral

21.

Crocker J, Liu K, Smith M, Nakamoto M, Mitchell C, Zhu E, et al. Early Impact of the COVID-19 Pandemic on Outpatient Neurologic Care in Hawai’i. Hawaii J Health Soc Welf. 2022;81(1):6–12.PubMedPubMedCentral

Title: Results of a Web-based survey of 2105 Greek migraine patients in 2020: demographics, clinical characteristics, burden and the effects of the COVID-19 pandemic on the course of migraine
Authors: Emmanouil V. Dermitzakis
Aikaterini Kouroudi
Andreas A. Argyriou
Konstantinos C. Spingos
Konstantinos Bilias
Michail Vikelis
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Migraine
COVID-19
Headache
Published in: BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI: https://doi.org/10.1186/s12883-022-02968-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Results of a Web-based survey of 2105 Greek migraine patients in 2020: demographics, clinical characteristics, burden and the effects of the COVID-19 pandemic on the course of migraine

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2022

Using Doppler sonography resistive index for the diagnosis of perinatal asphyxia: a multi-centered study

Cerebral blood flow abnormalities with central sparing on arterial spin labeling in mild encephalopathy associated with excitotoxicity: a case report

Recurrent amnesia caused by early seizures after hippocampal infarction: a case report

Bilateral paralysis of peroneal nerve after COVID-19 disease: a case report

Recurrent headache and visual symptoms in a young man: a rare neuronal intranuclear inclusion disease case report

Colostomy as a definitive treatment in an ALS patient with acute colonic Pseudo-obstruction refractory to medical management, a case report